MWM
AMED

Mascoma Wealth Management’s Amedisys AMED Stock Holding History

Mascoma Wealth Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-125
Closed -$12.3K – 459
2025
Q2 		$12.3K Hold
125
– – ﹤0.01% 302
2025
Q1 		$11.6K Hold
125
– – ﹤0.01% 315
2024
Q4 		$11.3K Hold
125
– – ﹤0.01% 336
2024
Q3 		$12.1K Hold
125
– – ﹤0.01% 309
2024
Q2 		$11.5K Buy
+125
New +$11.6K ﹤0.01% 323

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mascoma Wealth Management's AMED Position: Q3 2025 in Review

Mascoma Wealth Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 125 shares — an estimated $12.3K sold.

Mascoma Wealth Management first reported a position in AMED in Q2 2024 and held it in 5 quarters. The position peaked at $12.3K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Mascoma Wealth Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Mascoma Wealth Management sold 125 Amedisys shares in Q3 2025, an estimated $12.3K.
  • Mascoma Wealth Management first reported a position in Amedisys in Q2 2024 and held it in 5 quarters.
  • Mascoma Wealth Management's Amedisys position peaked at $12.3K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Mascoma Wealth Management's 13F filing for Q3 2025, filed 28 Oct 2025.